Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,536,182
+$48,814,491 QoQ
Shares Held
391,576
+71.3% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#258
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. ABBV ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
|
282,337 | $53,536,741 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,536,182 | 391,576 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $49,721,691 | 228,616 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $87,648,763 | 383,600 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $97,547,336 | 421,298 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $71,818,974 | 386,914 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $46,939,837 | 261,195 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $42,849,510 | 241,134 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $65,613,124 | 332,252 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $46,100,800 | 268,778 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $59,711,863 | 327,907 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $39,049,494 | 251,981 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $40,392,276 | 270,980 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,791,729 | 258,233 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,668,196 | 148,511 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $23,040,573 | 142,569 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $19,082,781 | 142,186 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $90,667,042 | 591,976 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $119,646,092 | 738,055 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $111,091,095 | 820,466 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $79,211,311 | 734,322 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $58,086,306 | 515,681 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $51,493,453 | 475,822 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $45,229,298 | 422,112 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,010,835 | 182,793 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $14,362,848 | 146,291 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $10,074,526 | 132,229 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||